SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-110572
Filing Date
2024-10-22
Accepted
2024-10-22 16:19:08
Documents
1
Group Members
AH BIO FUND IV, L.P.AH EQUITY PARTNERS BIO I, L.L.C.AH EQUITY PARTNERS BIO IV, L.L.C.BENJAMIN HOROWITZMARC ANDREESSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2426610d1_sc13g.htm SC 13G 114086
  Complete submission text file 0001104659-24-110572.txt   115899
Mailing Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025
Business Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025 650-798-3900
AH Bio Fund I, L.P. (Filed by) CIK: 0001656629 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Subject) CIK: 0001736730 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94655 | Film No.: 241386546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)